Puma Biotechnology Inc.

NASDAQ: PBYI · Real-Time Price · USD
5.73
0.41 (7.71%)
At close: Aug 15, 2025, 3:59 PM
5.79
1.05%
After-hours: Aug 15, 2025, 07:19 PM EDT

Puma Biotechnology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
30.28M 21.59M 2K -29.13M
Depreciation & Amortization
11.52M 11.52M 8.92M 10.6M
Stock-Based Compensation
8.24M 10.25M 11.83M 32.63M
Other Working Capital
-16.86M -7.38M -33.6M 9.23M
Other Non-Cash Items
-519K 1.51M 7.03M 7.2M
Deferred Income Tax
-7.08M n/a n/a n/a
Change in Working Capital
-3.54M -17.85M -43.58M -602K
Operating Cash Flow
38.92M 27.01M -15.8M 20.7M
Capital Expenditures
-56K -12.64M -7M n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-76.23M -23.81M -4.84M -38.07M
Sales Maturities Of Investments
55.85M 17.33M 18.94M 27.19M
Other Investing Acitivies
n/a -12.5M -4K -19K
Investing Cash Flow
-20.44M -19.13M 7.1M -10.9M
Debt Repayment
-33.33M n/a n/a -1.5M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-666K n/a -300K -30.4M
Financial Cash Flow
-33.85M n/a 12.2M -31.9M
Net Cash Flow
-15.37M 7.88M 3.5M -22.16M
Free Cash Flow
38.86M 14.37M -22.8M 20.7M